STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition

Scientists explored combination therapy using CD8 T cells engineered to express constitutively active STAT5 with vaccines. CD8 T cells were transduced with a retrovirus encoding the mouse gp100 T cell receptor.